nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—CYP2C9—Donepezil—Alzheimer's disease	0.235	1	CbGbCtD
Eprosartan—AGTR1—Arf6 trafficking events—BIN1—Alzheimer's disease	0.00795	0.0864	CbGpPWpGaD
Eprosartan—ABCC2—ABC-family proteins mediated transport—ABCA7—Alzheimer's disease	0.00522	0.0568	CbGpPWpGaD
Eprosartan—ABCC2—Codeine and Morphine Metabolism—CYP2D6—Alzheimer's disease	0.00459	0.0499	CbGpPWpGaD
Eprosartan—AGTR1—ACE Inhibitor Pathway—ACE—Alzheimer's disease	0.00369	0.0401	CbGpPWpGaD
Eprosartan—ABCC2—Constitutive Androstane Receptor Pathway—PPP2R4—Alzheimer's disease	0.00329	0.0358	CbGpPWpGaD
Eprosartan—ABCC2—Irinotecan Pathway—BCHE—Alzheimer's disease	0.00278	0.0302	CbGpPWpGaD
Eprosartan—Losartan—ACE—Alzheimer's disease	0.00229	1	CrCbGaD
Eprosartan—AGTR1—Allograft Rejection—LRRK2—Alzheimer's disease	0.00228	0.0248	CbGpPWpGaD
Eprosartan—AGTR1—ACE Inhibitor Pathway—NOS3—Alzheimer's disease	0.00172	0.0187	CbGpPWpGaD
Eprosartan—CYP2C9—CYP2E1 reactions—CYP2D6—Alzheimer's disease	0.00156	0.017	CbGpPWpGaD
Eprosartan—CYP2C9—Constitutive Androstane Receptor Pathway—PPP2R4—Alzheimer's disease	0.00145	0.0157	CbGpPWpGaD
Eprosartan—Muscular weakness—Rivastigmine—Alzheimer's disease	0.00133	0.00198	CcSEcCtD
Eprosartan—Hyperglycaemia—Donepezil—Alzheimer's disease	0.00132	0.00197	CcSEcCtD
Eprosartan—Depression—Donepezil—Alzheimer's disease	0.0013	0.00194	CcSEcCtD
Eprosartan—Flatulence—Galantamine—Alzheimer's disease	0.0013	0.00193	CcSEcCtD
Eprosartan—Angina pectoris—Memantine—Alzheimer's disease	0.00129	0.00193	CcSEcCtD
Eprosartan—Sweating increased—Memantine—Alzheimer's disease	0.00129	0.00193	CcSEcCtD
Eprosartan—Tension—Galantamine—Alzheimer's disease	0.00129	0.00193	CcSEcCtD
Eprosartan—Renal failure—Donepezil—Alzheimer's disease	0.00128	0.00191	CcSEcCtD
Eprosartan—Nervousness—Galantamine—Alzheimer's disease	0.00128	0.00191	CcSEcCtD
Eprosartan—Bronchitis—Memantine—Alzheimer's disease	0.00128	0.00191	CcSEcCtD
Eprosartan—Back pain—Galantamine—Alzheimer's disease	0.00127	0.0019	CcSEcCtD
Eprosartan—Urinary tract infection—Donepezil—Alzheimer's disease	0.00127	0.00189	CcSEcCtD
Eprosartan—Conjunctivitis—Donepezil—Alzheimer's disease	0.00127	0.00189	CcSEcCtD
Eprosartan—Angina pectoris—Rivastigmine—Alzheimer's disease	0.00127	0.00189	CcSEcCtD
Eprosartan—Sweating increased—Rivastigmine—Alzheimer's disease	0.00127	0.00189	CcSEcCtD
Eprosartan—Muscle spasms—Galantamine—Alzheimer's disease	0.00127	0.00189	CcSEcCtD
Eprosartan—Bronchitis—Rivastigmine—Alzheimer's disease	0.00125	0.00186	CcSEcCtD
Eprosartan—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.00125	0.0136	CbGpPWpGaD
Eprosartan—Haematuria—Donepezil—Alzheimer's disease	0.00124	0.00186	CcSEcCtD
Eprosartan—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.00124	0.00184	CcSEcCtD
Eprosartan—Tremor—Galantamine—Alzheimer's disease	0.00123	0.00184	CcSEcCtD
Eprosartan—Epistaxis—Donepezil—Alzheimer's disease	0.00123	0.00184	CcSEcCtD
Eprosartan—Pollakiuria—Memantine—Alzheimer's disease	0.00123	0.00183	CcSEcCtD
Eprosartan—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00122	0.00182	CcSEcCtD
Eprosartan—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.00121	0.0018	CcSEcCtD
Eprosartan—Pollakiuria—Rivastigmine—Alzheimer's disease	0.0012	0.00179	CcSEcCtD
Eprosartan—Hyperglycaemia—Memantine—Alzheimer's disease	0.0012	0.00179	CcSEcCtD
Eprosartan—AGTR1—Peptide ligand-binding receptors—PYY—Alzheimer's disease	0.00119	0.013	CbGpPWpGaD
Eprosartan—Bradycardia—Donepezil—Alzheimer's disease	0.00119	0.00178	CcSEcCtD
Eprosartan—Malaise—Galantamine—Alzheimer's disease	0.00119	0.00177	CcSEcCtD
Eprosartan—Vertigo—Galantamine—Alzheimer's disease	0.00118	0.00176	CcSEcCtD
Eprosartan—Depression—Memantine—Alzheimer's disease	0.00118	0.00176	CcSEcCtD
Eprosartan—Syncope—Galantamine—Alzheimer's disease	0.00118	0.00176	CcSEcCtD
Eprosartan—Rhinitis—Donepezil—Alzheimer's disease	0.00117	0.00175	CcSEcCtD
Eprosartan—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.00117	0.00175	CcSEcCtD
Eprosartan—Renal failure—Memantine—Alzheimer's disease	0.00116	0.00174	CcSEcCtD
Eprosartan—Palpitations—Galantamine—Alzheimer's disease	0.00116	0.00173	CcSEcCtD
Eprosartan—Pharyngitis—Donepezil—Alzheimer's disease	0.00116	0.00173	CcSEcCtD
Eprosartan—Neuropathy peripheral—Memantine—Alzheimer's disease	0.00116	0.00173	CcSEcCtD
Eprosartan—Loss of consciousness—Galantamine—Alzheimer's disease	0.00116	0.00172	CcSEcCtD
Eprosartan—Depression—Rivastigmine—Alzheimer's disease	0.00116	0.00172	CcSEcCtD
Eprosartan—Oedema peripheral—Donepezil—Alzheimer's disease	0.00115	0.00172	CcSEcCtD
Eprosartan—Urinary tract infection—Memantine—Alzheimer's disease	0.00115	0.00172	CcSEcCtD
Eprosartan—Conjunctivitis—Memantine—Alzheimer's disease	0.00115	0.00172	CcSEcCtD
Eprosartan—Cough—Galantamine—Alzheimer's disease	0.00115	0.00171	CcSEcCtD
Eprosartan—Renal failure—Rivastigmine—Alzheimer's disease	0.00114	0.0017	CcSEcCtD
Eprosartan—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.00114	0.00169	CcSEcCtD
Eprosartan—AGTR1—ACE Inhibitor Pathway—TGFB1—Alzheimer's disease	0.00114	0.0123	CbGpPWpGaD
Eprosartan—ABCC2—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.00113	0.0123	CbGpPWpGaD
Eprosartan—Haematuria—Memantine—Alzheimer's disease	0.00113	0.00168	CcSEcCtD
Eprosartan—Visual impairment—Donepezil—Alzheimer's disease	0.00113	0.00168	CcSEcCtD
Eprosartan—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.00113	0.00168	CcSEcCtD
Eprosartan—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.00113	0.00168	CcSEcCtD
Eprosartan—Chest pain—Galantamine—Alzheimer's disease	0.00112	0.00167	CcSEcCtD
Eprosartan—Arthralgia—Galantamine—Alzheimer's disease	0.00112	0.00167	CcSEcCtD
Eprosartan—Myalgia—Galantamine—Alzheimer's disease	0.00112	0.00167	CcSEcCtD
Eprosartan—Epistaxis—Memantine—Alzheimer's disease	0.00112	0.00167	CcSEcCtD
Eprosartan—Anxiety—Galantamine—Alzheimer's disease	0.00112	0.00166	CcSEcCtD
Eprosartan—Sinusitis—Memantine—Alzheimer's disease	0.00111	0.00166	CcSEcCtD
Eprosartan—Discomfort—Galantamine—Alzheimer's disease	0.00111	0.00165	CcSEcCtD
Eprosartan—Haematuria—Rivastigmine—Alzheimer's disease	0.00111	0.00165	CcSEcCtD
Eprosartan—Dry mouth—Galantamine—Alzheimer's disease	0.0011	0.00163	CcSEcCtD
Eprosartan—Epistaxis—Rivastigmine—Alzheimer's disease	0.00109	0.00163	CcSEcCtD
Eprosartan—Tinnitus—Donepezil—Alzheimer's disease	0.00109	0.00163	CcSEcCtD
Eprosartan—Sinusitis—Rivastigmine—Alzheimer's disease	0.00109	0.00162	CcSEcCtD
Eprosartan—Bradycardia—Memantine—Alzheimer's disease	0.00108	0.00161	CcSEcCtD
Eprosartan—Rhinitis—Memantine—Alzheimer's disease	0.00107	0.00159	CcSEcCtD
Eprosartan—Bradycardia—Rivastigmine—Alzheimer's disease	0.00106	0.00158	CcSEcCtD
Eprosartan—Shock—Galantamine—Alzheimer's disease	0.00106	0.00158	CcSEcCtD
Eprosartan—Pharyngitis—Memantine—Alzheimer's disease	0.00106	0.00157	CcSEcCtD
Eprosartan—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00105	0.00157	CcSEcCtD
Eprosartan—Chills—Donepezil—Alzheimer's disease	0.00105	0.00157	CcSEcCtD
Eprosartan—Tachycardia—Galantamine—Alzheimer's disease	0.00105	0.00156	CcSEcCtD
Eprosartan—Oedema peripheral—Memantine—Alzheimer's disease	0.00105	0.00156	CcSEcCtD
Eprosartan—Rhinitis—Rivastigmine—Alzheimer's disease	0.00104	0.00156	CcSEcCtD
Eprosartan—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00104	0.00155	CcSEcCtD
Eprosartan—Pharyngitis—Rivastigmine—Alzheimer's disease	0.00103	0.00154	CcSEcCtD
Eprosartan—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.00103	0.00153	CcSEcCtD
Eprosartan—Visual impairment—Memantine—Alzheimer's disease	0.00103	0.00153	CcSEcCtD
Eprosartan—Anorexia—Galantamine—Alzheimer's disease	0.00102	0.00153	CcSEcCtD
Eprosartan—Flatulence—Donepezil—Alzheimer's disease	0.001	0.0015	CcSEcCtD
Eprosartan—Hypotension—Galantamine—Alzheimer's disease	0.001	0.0015	CcSEcCtD
Eprosartan—Visual impairment—Rivastigmine—Alzheimer's disease	0.001	0.0015	CcSEcCtD
Eprosartan—Tension—Donepezil—Alzheimer's disease	0.001	0.00149	CcSEcCtD
Eprosartan—Tinnitus—Memantine—Alzheimer's disease	0.000992	0.00148	CcSEcCtD
Eprosartan—Nervousness—Donepezil—Alzheimer's disease	0.00099	0.00148	CcSEcCtD
Eprosartan—Back pain—Donepezil—Alzheimer's disease	0.000986	0.00147	CcSEcCtD
Eprosartan—Muscle spasms—Donepezil—Alzheimer's disease	0.00098	0.00146	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000978	0.00146	CcSEcCtD
Eprosartan—Insomnia—Galantamine—Alzheimer's disease	0.000971	0.00145	CcSEcCtD
Eprosartan—Tinnitus—Rivastigmine—Alzheimer's disease	0.00097	0.00145	CcSEcCtD
Eprosartan—CYP2C9—Xenobiotics—CYP2D6—Alzheimer's disease	0.000968	0.0105	CbGpPWpGaD
Eprosartan—Paraesthesia—Galantamine—Alzheimer's disease	0.000964	0.00144	CcSEcCtD
Eprosartan—Tremor—Donepezil—Alzheimer's disease	0.000955	0.00142	CcSEcCtD
Eprosartan—Somnolence—Galantamine—Alzheimer's disease	0.000955	0.00142	CcSEcCtD
Eprosartan—Chills—Memantine—Alzheimer's disease	0.000954	0.00142	CcSEcCtD
Eprosartan—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000946	0.00141	CcSEcCtD
Eprosartan—Dyspepsia—Galantamine—Alzheimer's disease	0.000945	0.00141	CcSEcCtD
Eprosartan—Chills—Rivastigmine—Alzheimer's disease	0.000934	0.00139	CcSEcCtD
Eprosartan—Decreased appetite—Galantamine—Alzheimer's disease	0.000934	0.00139	CcSEcCtD
Eprosartan—CYP2C9—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	0.000931	0.0101	CbGpPWpGaD
Eprosartan—Fatigue—Galantamine—Alzheimer's disease	0.000926	0.00138	CcSEcCtD
Eprosartan—Malaise—Donepezil—Alzheimer's disease	0.00092	0.00137	CcSEcCtD
Eprosartan—Constipation—Galantamine—Alzheimer's disease	0.000918	0.00137	CcSEcCtD
Eprosartan—Vertigo—Donepezil—Alzheimer's disease	0.000916	0.00137	CcSEcCtD
Eprosartan—Syncope—Donepezil—Alzheimer's disease	0.000915	0.00136	CcSEcCtD
Eprosartan—Flatulence—Memantine—Alzheimer's disease	0.000912	0.00136	CcSEcCtD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—F2—Alzheimer's disease	0.000912	0.00992	CbGpPWpGaD
Eprosartan—Tension—Memantine—Alzheimer's disease	0.000909	0.00135	CcSEcCtD
Eprosartan—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.000906	0.00985	CbGpPWpGaD
Eprosartan—Nervousness—Memantine—Alzheimer's disease	0.000899	0.00134	CcSEcCtD
Eprosartan—Loss of consciousness—Donepezil—Alzheimer's disease	0.000896	0.00134	CcSEcCtD
Eprosartan—Back pain—Memantine—Alzheimer's disease	0.000896	0.00134	CcSEcCtD
Eprosartan—CYP2C9—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.000894	0.00972	CbGpPWpGaD
Eprosartan—Flatulence—Rivastigmine—Alzheimer's disease	0.000893	0.00133	CcSEcCtD
Eprosartan—Cough—Donepezil—Alzheimer's disease	0.00089	0.00133	CcSEcCtD
Eprosartan—Tension—Rivastigmine—Alzheimer's disease	0.000889	0.00133	CcSEcCtD
Eprosartan—Feeling abnormal—Galantamine—Alzheimer's disease	0.000885	0.00132	CcSEcCtD
Eprosartan—Nervousness—Rivastigmine—Alzheimer's disease	0.00088	0.00131	CcSEcCtD
Eprosartan—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000878	0.00131	CcSEcCtD
Eprosartan—Back pain—Rivastigmine—Alzheimer's disease	0.000876	0.00131	CcSEcCtD
Eprosartan—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000871	0.0013	CcSEcCtD
Eprosartan—Chest pain—Donepezil—Alzheimer's disease	0.000868	0.00129	CcSEcCtD
Eprosartan—Arthralgia—Donepezil—Alzheimer's disease	0.000868	0.00129	CcSEcCtD
Eprosartan—Myalgia—Donepezil—Alzheimer's disease	0.000868	0.00129	CcSEcCtD
Eprosartan—AGTR1—Arf6 trafficking events—INS—Alzheimer's disease	0.000868	0.00944	CbGpPWpGaD
Eprosartan—Tremor—Memantine—Alzheimer's disease	0.000868	0.00129	CcSEcCtD
Eprosartan—Anxiety—Donepezil—Alzheimer's disease	0.000865	0.00129	CcSEcCtD
Eprosartan—Ill-defined disorder—Memantine—Alzheimer's disease	0.000859	0.00128	CcSEcCtD
Eprosartan—Discomfort—Donepezil—Alzheimer's disease	0.000858	0.00128	CcSEcCtD
Eprosartan—Dry mouth—Donepezil—Alzheimer's disease	0.000849	0.00127	CcSEcCtD
Eprosartan—Abdominal pain—Galantamine—Alzheimer's disease	0.000849	0.00127	CcSEcCtD
Eprosartan—Body temperature increased—Galantamine—Alzheimer's disease	0.000849	0.00127	CcSEcCtD
Eprosartan—Tremor—Rivastigmine—Alzheimer's disease	0.000849	0.00127	CcSEcCtD
Eprosartan—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.00084	0.00125	CcSEcCtD
Eprosartan—Malaise—Memantine—Alzheimer's disease	0.000835	0.00125	CcSEcCtD
Eprosartan—Vertigo—Memantine—Alzheimer's disease	0.000832	0.00124	CcSEcCtD
Eprosartan—Syncope—Memantine—Alzheimer's disease	0.00083	0.00124	CcSEcCtD
Eprosartan—AGTR1—Peptide ligand-binding receptors—GAL—Alzheimer's disease	0.000827	0.00899	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL1A—Alzheimer's disease	0.00082	0.00891	CbGpPWpGaD
Eprosartan—Shock—Donepezil—Alzheimer's disease	0.000819	0.00122	CcSEcCtD
Eprosartan—Palpitations—Memantine—Alzheimer's disease	0.000818	0.00122	CcSEcCtD
Eprosartan—Malaise—Rivastigmine—Alzheimer's disease	0.000817	0.00122	CcSEcCtD
Eprosartan—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000815	0.00122	CcSEcCtD
Eprosartan—Vertigo—Rivastigmine—Alzheimer's disease	0.000814	0.00121	CcSEcCtD
Eprosartan—Loss of consciousness—Memantine—Alzheimer's disease	0.000814	0.00121	CcSEcCtD
Eprosartan—Syncope—Rivastigmine—Alzheimer's disease	0.000812	0.00121	CcSEcCtD
Eprosartan—Cough—Memantine—Alzheimer's disease	0.000808	0.0012	CcSEcCtD
Eprosartan—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000805	0.0012	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—PYY—Alzheimer's disease	0.000801	0.0087	CbGpPWpGaD
Eprosartan—Palpitations—Rivastigmine—Alzheimer's disease	0.0008	0.00119	CcSEcCtD
Eprosartan—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000796	0.00119	CcSEcCtD
Eprosartan—Anorexia—Donepezil—Alzheimer's disease	0.000793	0.00118	CcSEcCtD
Eprosartan—Hypersensitivity—Galantamine—Alzheimer's disease	0.000791	0.00118	CcSEcCtD
Eprosartan—Cough—Rivastigmine—Alzheimer's disease	0.00079	0.00118	CcSEcCtD
Eprosartan—Chest pain—Memantine—Alzheimer's disease	0.000788	0.00118	CcSEcCtD
Eprosartan—Arthralgia—Memantine—Alzheimer's disease	0.000788	0.00118	CcSEcCtD
Eprosartan—Myalgia—Memantine—Alzheimer's disease	0.000788	0.00118	CcSEcCtD
Eprosartan—Anxiety—Memantine—Alzheimer's disease	0.000786	0.00117	CcSEcCtD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR6—Alzheimer's disease	0.00078	0.00848	CbGpPWpGaD
Eprosartan—Discomfort—Memantine—Alzheimer's disease	0.000779	0.00116	CcSEcCtD
Eprosartan—Hypotension—Donepezil—Alzheimer's disease	0.000778	0.00116	CcSEcCtD
Eprosartan—AGTR1—Peptide GPCRs—CCR5—Alzheimer's disease	0.000777	0.00845	CbGpPWpGaD
Eprosartan—Arthralgia—Rivastigmine—Alzheimer's disease	0.000771	0.00115	CcSEcCtD
Eprosartan—Chest pain—Rivastigmine—Alzheimer's disease	0.000771	0.00115	CcSEcCtD
Eprosartan—Myalgia—Rivastigmine—Alzheimer's disease	0.000771	0.00115	CcSEcCtD
Eprosartan—Dry mouth—Memantine—Alzheimer's disease	0.000771	0.00115	CcSEcCtD
Eprosartan—Asthenia—Galantamine—Alzheimer's disease	0.000771	0.00115	CcSEcCtD
Eprosartan—Anxiety—Rivastigmine—Alzheimer's disease	0.000769	0.00115	CcSEcCtD
Eprosartan—Discomfort—Rivastigmine—Alzheimer's disease	0.000762	0.00114	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000758	0.00113	CcSEcCtD
Eprosartan—Dry mouth—Rivastigmine—Alzheimer's disease	0.000754	0.00112	CcSEcCtD
Eprosartan—Insomnia—Donepezil—Alzheimer's disease	0.000753	0.00112	CcSEcCtD
Eprosartan—Paraesthesia—Donepezil—Alzheimer's disease	0.000747	0.00111	CcSEcCtD
Eprosartan—Shock—Memantine—Alzheimer's disease	0.000743	0.00111	CcSEcCtD
Eprosartan—Dyspnoea—Donepezil—Alzheimer's disease	0.000742	0.00111	CcSEcCtD
Eprosartan—Somnolence—Donepezil—Alzheimer's disease	0.00074	0.0011	CcSEcCtD
Eprosartan—Thrombocytopenia—Memantine—Alzheimer's disease	0.00074	0.0011	CcSEcCtD
Eprosartan—Tachycardia—Memantine—Alzheimer's disease	0.000738	0.0011	CcSEcCtD
Eprosartan—Diarrhoea—Galantamine—Alzheimer's disease	0.000735	0.0011	CcSEcCtD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.000735	0.00799	CbGpPWpGaD
Eprosartan—Dyspepsia—Donepezil—Alzheimer's disease	0.000733	0.00109	CcSEcCtD
Eprosartan—Hyperhidrosis—Memantine—Alzheimer's disease	0.000731	0.00109	CcSEcCtD
Eprosartan—Shock—Rivastigmine—Alzheimer's disease	0.000727	0.00108	CcSEcCtD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NOS3—Alzheimer's disease	0.000725	0.00788	CbGpPWpGaD
Eprosartan—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000724	0.00108	CcSEcCtD
Eprosartan—Decreased appetite—Donepezil—Alzheimer's disease	0.000724	0.00108	CcSEcCtD
Eprosartan—Tachycardia—Rivastigmine—Alzheimer's disease	0.000722	0.00108	CcSEcCtD
Eprosartan—Anorexia—Memantine—Alzheimer's disease	0.00072	0.00107	CcSEcCtD
Eprosartan—Fatigue—Donepezil—Alzheimer's disease	0.000718	0.00107	CcSEcCtD
Eprosartan—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000716	0.00778	CbGpPWpGaD
Eprosartan—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000715	0.00107	CcSEcCtD
Eprosartan—Pain—Donepezil—Alzheimer's disease	0.000712	0.00106	CcSEcCtD
Eprosartan—Constipation—Donepezil—Alzheimer's disease	0.000712	0.00106	CcSEcCtD
Eprosartan—Dizziness—Galantamine—Alzheimer's disease	0.00071	0.00106	CcSEcCtD
Eprosartan—Hypotension—Memantine—Alzheimer's disease	0.000706	0.00105	CcSEcCtD
Eprosartan—Anorexia—Rivastigmine—Alzheimer's disease	0.000705	0.00105	CcSEcCtD
Eprosartan—Hypotension—Rivastigmine—Alzheimer's disease	0.000691	0.00103	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000688	0.00103	CcSEcCtD
Eprosartan—Feeling abnormal—Donepezil—Alzheimer's disease	0.000686	0.00102	CcSEcCtD
Eprosartan—Insomnia—Memantine—Alzheimer's disease	0.000683	0.00102	CcSEcCtD
Eprosartan—Vomiting—Galantamine—Alzheimer's disease	0.000683	0.00102	CcSEcCtD
Eprosartan—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000681	0.00101	CcSEcCtD
Eprosartan—Paraesthesia—Memantine—Alzheimer's disease	0.000679	0.00101	CcSEcCtD
Eprosartan—Rash—Galantamine—Alzheimer's disease	0.000677	0.00101	CcSEcCtD
Eprosartan—Dermatitis—Galantamine—Alzheimer's disease	0.000677	0.00101	CcSEcCtD
Eprosartan—Dyspnoea—Memantine—Alzheimer's disease	0.000674	0.001	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000674	0.001	CcSEcCtD
Eprosartan—Headache—Galantamine—Alzheimer's disease	0.000673	0.001	CcSEcCtD
Eprosartan—Somnolence—Memantine—Alzheimer's disease	0.000672	0.001	CcSEcCtD
Eprosartan—Insomnia—Rivastigmine—Alzheimer's disease	0.000669	0.000997	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR6—Alzheimer's disease	0.000668	0.00726	CbGpPWpGaD
Eprosartan—Dyspepsia—Memantine—Alzheimer's disease	0.000665	0.000992	CcSEcCtD
Eprosartan—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000664	0.00099	CcSEcCtD
Eprosartan—Urticaria—Donepezil—Alzheimer's disease	0.000661	0.000986	CcSEcCtD
Eprosartan—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000659	0.000983	CcSEcCtD
Eprosartan—Body temperature increased—Donepezil—Alzheimer's disease	0.000658	0.000981	CcSEcCtD
Eprosartan—Abdominal pain—Donepezil—Alzheimer's disease	0.000658	0.000981	CcSEcCtD
Eprosartan—Somnolence—Rivastigmine—Alzheimer's disease	0.000657	0.00098	CcSEcCtD
Eprosartan—Decreased appetite—Memantine—Alzheimer's disease	0.000657	0.00098	CcSEcCtD
Eprosartan—Fatigue—Memantine—Alzheimer's disease	0.000652	0.000972	CcSEcCtD
Eprosartan—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000651	0.00097	CcSEcCtD
Eprosartan—AGTR1—Peptide ligand-binding receptors—NPY—Alzheimer's disease	0.00065	0.00707	CbGpPWpGaD
Eprosartan—Constipation—Memantine—Alzheimer's disease	0.000646	0.000964	CcSEcCtD
Eprosartan—Pain—Memantine—Alzheimer's disease	0.000646	0.000964	CcSEcCtD
Eprosartan—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000643	0.000958	CcSEcCtD
Eprosartan—Nausea—Galantamine—Alzheimer's disease	0.000638	0.000951	CcSEcCtD
Eprosartan—Fatigue—Rivastigmine—Alzheimer's disease	0.000637	0.00095	CcSEcCtD
Eprosartan—Constipation—Rivastigmine—Alzheimer's disease	0.000632	0.000943	CcSEcCtD
Eprosartan—Pain—Rivastigmine—Alzheimer's disease	0.000632	0.000943	CcSEcCtD
Eprosartan—Feeling abnormal—Memantine—Alzheimer's disease	0.000623	0.000929	CcSEcCtD
Eprosartan—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000618	0.000921	CcSEcCtD
Eprosartan—Hypersensitivity—Donepezil—Alzheimer's disease	0.000613	0.000914	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—PYY—Alzheimer's disease	0.00061	0.00663	CbGpPWpGaD
Eprosartan—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000609	0.000908	CcSEcCtD
Eprosartan—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000605	0.000901	CcSEcCtD
Eprosartan—AGTR1—G alpha (q) signalling events—NPS—Alzheimer's disease	0.000602	0.00654	CbGpPWpGaD
Eprosartan—Urticaria—Memantine—Alzheimer's disease	0.0006	0.000895	CcSEcCtD
Eprosartan—Abdominal pain—Memantine—Alzheimer's disease	0.000597	0.000891	CcSEcCtD
Eprosartan—Body temperature increased—Memantine—Alzheimer's disease	0.000597	0.000891	CcSEcCtD
Eprosartan—Asthenia—Donepezil—Alzheimer's disease	0.000597	0.00089	CcSEcCtD
Eprosartan—AGTR1—Peptide ligand-binding receptors—NPS—Alzheimer's disease	0.000594	0.00646	CbGpPWpGaD
Eprosartan—Pruritus—Donepezil—Alzheimer's disease	0.000589	0.000878	CcSEcCtD
Eprosartan—Urticaria—Rivastigmine—Alzheimer's disease	0.000587	0.000876	CcSEcCtD
Eprosartan—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000584	0.000871	CcSEcCtD
Eprosartan—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000584	0.000871	CcSEcCtD
Eprosartan—Diarrhoea—Donepezil—Alzheimer's disease	0.000569	0.000849	CcSEcCtD
Eprosartan—AGTR1—Peptide ligand-binding receptors—SST—Alzheimer's disease	0.000567	0.00616	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MAPK8—Alzheimer's disease	0.000565	0.00615	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—APP—Alzheimer's disease	0.00056	0.00608	CbGpPWpGaD
Eprosartan—Hypersensitivity—Memantine—Alzheimer's disease	0.000557	0.00083	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—GAL—Alzheimer's disease	0.000555	0.00603	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—APP—Alzheimer's disease	0.000553	0.00601	CbGpPWpGaD
Eprosartan—Dizziness—Donepezil—Alzheimer's disease	0.00055	0.000821	CcSEcCtD
Eprosartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.000549	0.00597	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ABCA7—Alzheimer's disease	0.000546	0.00593	CbGpPWpGaD
Eprosartan—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000545	0.000812	CcSEcCtD
Eprosartan—Asthenia—Memantine—Alzheimer's disease	0.000542	0.000809	CcSEcCtD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—Alzheimer's disease	0.000538	0.00585	CbGpPWpGaD
Eprosartan—Pruritus—Memantine—Alzheimer's disease	0.000535	0.000797	CcSEcCtD
Eprosartan—Asthenia—Rivastigmine—Alzheimer's disease	0.00053	0.000791	CcSEcCtD
Eprosartan—Vomiting—Donepezil—Alzheimer's disease	0.000529	0.000789	CcSEcCtD
Eprosartan—AGTR1—G alpha (q) signalling events—PLCB1—Alzheimer's disease	0.000528	0.00574	CbGpPWpGaD
Eprosartan—Rash—Donepezil—Alzheimer's disease	0.000525	0.000783	CcSEcCtD
Eprosartan—Dermatitis—Donepezil—Alzheimer's disease	0.000524	0.000782	CcSEcCtD
Eprosartan—Pruritus—Rivastigmine—Alzheimer's disease	0.000523	0.00078	CcSEcCtD
Eprosartan—Headache—Donepezil—Alzheimer's disease	0.000521	0.000777	CcSEcCtD
Eprosartan—Diarrhoea—Memantine—Alzheimer's disease	0.000517	0.000771	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—HTR6—Alzheimer's disease	0.000509	0.00553	CbGpPWpGaD
Eprosartan—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000506	0.000754	CcSEcCtD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—APP—Alzheimer's disease	0.000501	0.00544	CbGpPWpGaD
Eprosartan—Dizziness—Memantine—Alzheimer's disease	0.0005	0.000745	CcSEcCtD
Eprosartan—CYP2C9—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.000497	0.0054	CbGpPWpGaD
Eprosartan—Nausea—Donepezil—Alzheimer's disease	0.000494	0.000737	CcSEcCtD
Eprosartan—Dizziness—Rivastigmine—Alzheimer's disease	0.000489	0.000729	CcSEcCtD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	0.000486	0.00529	CbGpPWpGaD
Eprosartan—Vomiting—Memantine—Alzheimer's disease	0.00048	0.000716	CcSEcCtD
Eprosartan—Rash—Memantine—Alzheimer's disease	0.000476	0.000711	CcSEcCtD
Eprosartan—Dermatitis—Memantine—Alzheimer's disease	0.000476	0.00071	CcSEcCtD
Eprosartan—CYP2C9—Arachidonic acid metabolism—PTGS1—Alzheimer's disease	0.000474	0.00515	CbGpPWpGaD
Eprosartan—Headache—Memantine—Alzheimer's disease	0.000473	0.000706	CcSEcCtD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PLCB1—Alzheimer's disease	0.000472	0.00513	CbGpPWpGaD
Eprosartan—Vomiting—Rivastigmine—Alzheimer's disease	0.00047	0.000701	CcSEcCtD
Eprosartan—Rash—Rivastigmine—Alzheimer's disease	0.000466	0.000695	CcSEcCtD
Eprosartan—Dermatitis—Rivastigmine—Alzheimer's disease	0.000466	0.000694	CcSEcCtD
Eprosartan—Headache—Rivastigmine—Alzheimer's disease	0.000463	0.000691	CcSEcCtD
Eprosartan—ABCC2—NRF2 pathway—SLC6A4—Alzheimer's disease	0.000449	0.00488	CbGpPWpGaD
Eprosartan—Nausea—Memantine—Alzheimer's disease	0.000449	0.000669	CcSEcCtD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—Alzheimer's disease	0.000447	0.00486	CbGpPWpGaD
Eprosartan—Nausea—Rivastigmine—Alzheimer's disease	0.000439	0.000655	CcSEcCtD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000438	0.00477	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—NPY—Alzheimer's disease	0.000436	0.00474	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL1B—Alzheimer's disease	0.000428	0.00465	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—CASP3—Alzheimer's disease	0.000427	0.00464	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—GAL—Alzheimer's disease	0.000423	0.00459	CbGpPWpGaD
Eprosartan—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000402	0.00437	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—NPS—Alzheimer's disease	0.000399	0.00433	CbGpPWpGaD
Eprosartan—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000397	0.00431	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—CYP46A1—Alzheimer's disease	0.00039	0.00424	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000385	0.00418	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—SST—Alzheimer's disease	0.00038	0.00413	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—APP—Alzheimer's disease	0.000371	0.00403	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCR5—Alzheimer's disease	0.000365	0.00397	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—HTR2A—Alzheimer's disease	0.000362	0.00394	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—VEGFA—Alzheimer's disease	0.000362	0.00394	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PYY—Alzheimer's disease	0.000345	0.00375	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	0.000337	0.00366	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—HMOX1—Alzheimer's disease	0.000334	0.00363	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—AKT1—Alzheimer's disease	0.000333	0.00362	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—TGFB1—Alzheimer's disease	0.000332	0.00361	CbGpPWpGaD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000332	0.00361	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—NPY—Alzheimer's disease	0.000332	0.00361	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—IAPP—Alzheimer's disease	0.00033	0.00359	CbGpPWpGaD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000326	0.00354	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Alzheimer's disease	0.000324	0.00352	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CRH—Alzheimer's disease	0.00032	0.00348	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—F2—Alzheimer's disease	0.000318	0.00345	CbGpPWpGaD
Eprosartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000314	0.00342	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—F2—Alzheimer's disease	0.000313	0.00341	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PYY—Alzheimer's disease	0.000313	0.0034	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—TNF—Alzheimer's disease	0.00031	0.00337	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—NPS—Alzheimer's disease	0.000304	0.0033	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—AGER—Alzheimer's disease	0.0003	0.00326	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—SST—Alzheimer's disease	0.00029	0.00315	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—HTR6—Alzheimer's disease	0.000288	0.00313	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—APOD—Alzheimer's disease	0.000287	0.00312	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	0.000286	0.00311	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—Alzheimer's disease	0.000284	0.00309	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—APP—Alzheimer's disease	0.000282	0.00307	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	0.00028	0.00304	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCL2—Alzheimer's disease	0.000279	0.00304	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CDK5—Alzheimer's disease	0.000271	0.00295	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HTR6—Alzheimer's disease	0.000261	0.00284	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—CREB1—Alzheimer's disease	0.000259	0.00281	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	0.000245	0.00266	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	0.00024	0.00261	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—GAL—Alzheimer's disease	0.000239	0.0026	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—MAOB—Alzheimer's disease	0.000233	0.00253	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.000225	0.00244	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—GAL—Alzheimer's disease	0.000217	0.00236	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TTR—Alzheimer's disease	0.000211	0.0023	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	0.00021	0.00229	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—NPY—Alzheimer's disease	0.000188	0.00204	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	0.000187	0.00204	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CCR5—Alzheimer's disease	0.000187	0.00203	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—IAPP—Alzheimer's disease	0.000186	0.00203	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PYY—Alzheimer's disease	0.000185	0.00201	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—HTR2A—Alzheimer's disease	0.000183	0.00199	CbGpPWpGaD
Eprosartan—CYP2C9—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	0.000182	0.00198	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CRH—Alzheimer's disease	0.000181	0.00197	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—CP—Alzheimer's disease	0.00018	0.00196	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—PTGS1—Alzheimer's disease	0.000176	0.00192	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—CYP2D6—Alzheimer's disease	0.000173	0.00188	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—NPS—Alzheimer's disease	0.000172	0.00187	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.000171	0.00186	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—NPY—Alzheimer's disease	0.00017	0.00185	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IAPP—Alzheimer's disease	0.000169	0.00184	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CRH—Alzheimer's disease	0.000164	0.00179	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000164	0.00178	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—SST—Alzheimer's disease	0.000164	0.00178	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	0.000162	0.00177	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CDK5—Alzheimer's disease	0.00016	0.00174	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—F2—Alzheimer's disease	0.00016	0.00174	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—APP—Alzheimer's disease	0.00016	0.00173	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—NPS—Alzheimer's disease	0.000156	0.00169	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000155	0.00169	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HTR6—Alzheimer's disease	0.000154	0.00168	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—TF—Alzheimer's disease	0.000153	0.00166	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000151	0.00164	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	0.00015	0.00163	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—SST—Alzheimer's disease	0.000149	0.00162	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—GAB2—Alzheimer's disease	0.000149	0.00162	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—APP—Alzheimer's disease	0.000145	0.00157	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CCL2—Alzheimer's disease	0.000143	0.00155	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PSENEN—Alzheimer's disease	0.00014	0.00152	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—APH1A—Alzheimer's disease	0.000138	0.0015	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000137	0.00149	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NCSTN—Alzheimer's disease	0.000134	0.00146	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—LRP1—Alzheimer's disease	0.000131	0.00143	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GFAP—Alzheimer's disease	0.000128	0.00139	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GAL—Alzheimer's disease	0.000128	0.00139	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—TGFB1—Alzheimer's disease	0.000127	0.00138	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—A2M—Alzheimer's disease	0.000113	0.00123	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	0.000112	0.00122	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000111	0.00121	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PSEN2—Alzheimer's disease	0.000109	0.00119	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	0.000107	0.00116	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000105	0.00115	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000103	0.00112	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000101	0.0011	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NPY—Alzheimer's disease	0.000101	0.00109	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—DHCR24—Alzheimer's disease	0.0001	0.00109	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IAPP—Alzheimer's disease	0.0001	0.00109	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CRH—Alzheimer's disease	9.71e-05	0.00106	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCR5—Alzheimer's disease	9.58e-05	0.00104	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HTR2A—Alzheimer's disease	9.37e-05	0.00102	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	9.33e-05	0.00101	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NPS—Alzheimer's disease	9.2e-05	0.001	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PPP3CA—Alzheimer's disease	9.16e-05	0.000996	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—F2—Alzheimer's disease	9.05e-05	0.000984	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PTK2B—Alzheimer's disease	9.03e-05	0.000981	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GAB2—Alzheimer's disease	8.78e-05	0.000955	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SST—Alzheimer's disease	8.78e-05	0.000955	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NTRK2—Alzheimer's disease	8.78e-05	0.000955	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CALM1—Alzheimer's disease	8.74e-05	0.000951	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GSK3A—Alzheimer's disease	8.7e-05	0.000946	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—APP—Alzheimer's disease	8.56e-05	0.00093	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CA4—Alzheimer's disease	8.51e-05	0.000925	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	8.31e-05	0.000904	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—F2—Alzheimer's disease	8.22e-05	0.000893	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PLCB1—Alzheimer's disease	8.07e-05	0.000878	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GAPDHS—Alzheimer's disease	8e-05	0.000869	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ATP5A1—Alzheimer's disease	7.58e-05	0.000824	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NGFR—Alzheimer's disease	7.53e-05	0.000819	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CREB1—Alzheimer's disease	7.49e-05	0.000814	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ADAM10—Alzheimer's disease	7.36e-05	0.0008	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCL2—Alzheimer's disease	7.32e-05	0.000796	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PLD3—Alzheimer's disease	7.23e-05	0.000786	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	7.23e-05	0.000786	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	7.15e-05	0.000777	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—S100B—Alzheimer's disease	6.96e-05	0.000756	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	6.93e-05	0.000754	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	6.78e-05	0.000737	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	6.67e-05	0.000726	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IGF2—Alzheimer's disease	6.62e-05	0.00072	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ND1—Alzheimer's disease	6.45e-05	0.000701	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IGF1R—Alzheimer's disease	6.41e-05	0.000696	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	6.3e-05	0.000685	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—LPL—Alzheimer's disease	6.14e-05	0.000668	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MEF2C—Alzheimer's disease	6.09e-05	0.000662	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PRKCG—Alzheimer's disease	5.97e-05	0.000649	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NGF—Alzheimer's disease	5.82e-05	0.000632	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	5.76e-05	0.000626	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCR5—Alzheimer's disease	5.66e-05	0.000615	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HTR2A—Alzheimer's disease	5.54e-05	0.000602	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CALM1—Alzheimer's disease	5.17e-05	0.000562	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—LEP—Alzheimer's disease	5.15e-05	0.00056	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—APOE—Alzheimer's disease	5.15e-05	0.00056	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CAV1—Alzheimer's disease	5.1e-05	0.000554	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	4.97e-05	0.00054	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ESR1—Alzheimer's disease	4.91e-05	0.000534	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—F2—Alzheimer's disease	4.85e-05	0.000528	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NOTCH1—Alzheimer's disease	4.75e-05	0.000516	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	4.52e-05	0.000492	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GSK3B—Alzheimer's disease	4.46e-05	0.000485	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CREB1—Alzheimer's disease	4.42e-05	0.000481	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—INS—Alzheimer's disease	4.4e-05	0.000478	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCL2—Alzheimer's disease	4.33e-05	0.00047	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IGF1—Alzheimer's disease	4.25e-05	0.000462	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CHAT—Alzheimer's disease	4.15e-05	0.000452	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—TPI1—Alzheimer's disease	4.15e-05	0.000452	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—MAOB—Alzheimer's disease	3.98e-05	0.000433	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NOS3—Alzheimer's disease	3.86e-05	0.000419	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	3.83e-05	0.000417	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	3.79e-05	0.000412	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	3.76e-05	0.000408	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—A2M—Alzheimer's disease	3.7e-05	0.000402	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—AKT1—Alzheimer's disease	3.3e-05	0.000359	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	3.3e-05	0.000359	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CASP3—Alzheimer's disease	3.27e-05	0.000356	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL6—Alzheimer's disease	3.25e-05	0.000354	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ACHE—Alzheimer's disease	3.22e-05	0.00035	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	3.18e-05	0.000346	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ENO1—Alzheimer's disease	3.02e-05	0.000328	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	3.02e-05	0.000328	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MAPK8—Alzheimer's disease	3.01e-05	0.000327	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—AKT1—Alzheimer's disease	3e-05	0.000326	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	2.96e-05	0.000322	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—BCHE—Alzheimer's disease	2.81e-05	0.000305	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—VEGFA—Alzheimer's disease	2.78e-05	0.000302	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	2.65e-05	0.000288	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.6e-05	0.000282	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	2.57e-05	0.000279	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TGFB1—Alzheimer's disease	2.55e-05	0.000277	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	2.21e-05	0.00024	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	2.2e-05	0.000239	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TP53—Alzheimer's disease	2.1e-05	0.000228	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—LPL—Alzheimer's disease	2.01e-05	0.000219	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL6—Alzheimer's disease	1.92e-05	0.000209	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	1.81e-05	0.000197	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—AKT1—Alzheimer's disease	1.77e-05	0.000193	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CALM1—Alzheimer's disease	1.69e-05	0.000184	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—APOE—Alzheimer's disease	1.69e-05	0.000183	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CAV1—Alzheimer's disease	1.67e-05	0.000182	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PPARG—Alzheimer's disease	1.47e-05	0.00016	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—INS—Alzheimer's disease	1.44e-05	0.000157	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—NOS3—Alzheimer's disease	1.26e-05	0.000137	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	1.16e-05	0.000126	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—AKT1—Alzheimer's disease	5.81e-06	6.32e-05	CbGpPWpGaD
